Status:
UNKNOWN
Low-field Thoracic Magnetic Stimulation Increases Peripheral Oxygen Saturation Levels in COVID-19 Patients
Lead Sponsor:
Elias Manjarrez
Collaborating Sponsors:
National Council of Science and Technology, Mexico
Conditions:
COVID-19
Acute Respiratory Failure
Eligibility:
All Genders
20-85 years
Phase:
NA
Brief Summary
This study aimed to present a proof-of-concept that a 30 minutes single-session of low-field thoracic magnetic stimulation (LF-ThMS) on the dorsal thorax can be employed to increase oxygen saturation ...
Detailed Description
The severe acute respiratory syndrome coronavirus (CoV)-2 (SARS-CoV-2) may cause low SpO2 and respiratory failure in COVID-19 patients. Hence the increase of SpO2 levels could be crucial for the quali...
Eligibility Criteria
Inclusion
- Adult participants diagnosed with mild to moderate COVID-19 disease without pneumonia.
- COVID-19 participants with a SpO2 level less or equal to 90 %, exhibiting difficulty breathing, but not intubated.
- COVID-19 participants with similar pharmacological treatment against COVID-19.
- 20-85 years old
Exclusion
- COVID-19 patients with acute respiratory failure requiring urgent intubation
- COVID-19 patients with impaired consciousness
- Pregnant woman
- Patients with metallic implants in the thorax, abdomen, or arms, or with electronic medical devices such as pacemakers
- Children
Key Trial Info
Start Date :
July 3 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 17 2022
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT04895267
Start Date
July 3 2020
End Date
September 17 2022
Last Update
March 16 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Benemérita Universidad Autónoma de Puebla
Puebla City, Mexico, 72570